Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 485  
Year : 2019  |  Volume : 18  |  Issue : 1  |  Page : 8-12

A tribute to Dr. Saul Hertz: The discovery of the medical uses of radioiodine

Curator, Dr. Saul Hertz Archives and Saul Hertz MD.com, USA

Correspondence Address:
Barbara Hertz
Dr. Saul Hertz Archives and Saul Hertz MD.com, 6 Buckthorne Lane, Greenwich - 06830, CT
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/wjnm.WJNM_107_18

Rights and Permissions

Dr. Saul Hertz was Director of The Massachusetts General Hospital's Thyroid Unit, when he heard about the development of artificial radioactivity. He conceived and brought from bench to bedside the successful use of radioiodine (RAI) to diagnose and treat thyroid diseases. Thus was born the science of theragnostics used today for neuroendorine tumors and prostate cancer. Dr. Hertz's work set the foundation of targeted precision medicine.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded569    
    Comments [Add]    
    Cited by others 10    

Recommend this journal